Skip to main content

Peer Review reports

From: RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin

Original Submission
2 Nov 2020 Submitted Original manuscript
16 Dec 2020 Reviewed Reviewer Report
11 Jan 2021 Reviewed Reviewer Report
16 Feb 2021 Author responded Author comments - Wendy Muñoz-Montaño
Resubmission - Version 2
16 Feb 2021 Submitted Manuscript version 2
9 Mar 2021 Reviewed Reviewer Report
23 Mar 2021 Reviewed Reviewer Report
2 Apr 2021 Author responded Author comments - Wendy Muñoz-Montaño
Resubmission - Version 3
2 Apr 2021 Submitted Manuscript version 3
27 Apr 2021 Author responded Author comments - Wendy Muñoz-Montaño
Resubmission - Version 4
27 Apr 2021 Submitted Manuscript version 4
Publishing
4 May 2021 Editorially accepted
5 Aug 2021 Article published 10.1186/s12885-021-08287-5

You can find further information about peer review here.

Back to article page